Healthcare Services

Blood plasma derivatives market projected to reach $86.67B by 2030 at 9.3% CAGR

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Blood Plasma Derivatives Market Be By 2030 Compared To Its 2026 Market Size?

The blood plasma derivatives market has shown significant growth in recent years. Its value is expected to increase from $55.76 billion in 2025 to $60.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.0%. Historically, this expansion has been driven by a rising diagnosis of rare blood disorders, the expansion of plasma collection programs, increased demand for albumin therapies, enhancements in plasma fractionation techniques, and the growing use of plasma in hospitals.

The blood plasma derivatives market size is anticipated to experience substantial growth in the next few years, with projections indicating an increase to $86.68 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period is attributable to the increasing prevalence of immunodeficiency diseases, rising investments in plasma-derived therapeutics, the expansion of global plasma donation networks, a growing focus on self-sufficiency in plasma supply, and advancements in recombinant protein technologies. Key trends throughout this period include an increasing demand for immunoglobulin therapies, rising adoption of recombinant plasma products, the expansion of fractionation and purification technologies, a growing focus on pathogen reduction processes, and enhanced cold chain and plasma processing efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

What Factors Are Contributing To The Growth Of The Blood Plasma Derivatives Market?

The rising occurrence of hemophilia is projected to fuel the expansion of the blood plasma derivatives market. Hemophilia is defined as a genetic bleeding disorder where the blood fails to coagulate correctly. This condition can lead to both unprompted bleeding and hemorrhage following trauma or surgical procedures. For individuals experiencing hereditary or acquired difficulties with hemostasis, medications or products derived from blood plasma can effectively enhance blood clotting. Factor VIII, factor VIII/vWF, and factor IX concentrates are utilized in the respective treatments for hemophilia A, von Willebrand disease, and hemophilia B. As an illustration, the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) data for 2024, published in October 2025, shows a 6% increase in the worldwide recognition of hemophilia patients, a 6% increase in those diagnosed with VWD, and a 9% increase in the identification of other inherited bleeding conditions. Consequently, the growing incidence of hemophilia is propelling the expansion of the blood plasma derivatives market.

What Segment Categories Shape The Blood Plasma Derivatives Market Segment Landscape?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

What Trends Are Shaping The Future Of The Blood Plasma Derivatives Market?

Companies prominent in the blood plasma derivatives market are concentrating on supply chain improvements, particularly for intravenous immunoglobulin, which supports the immune system by supplying functional antibodies to individuals with immunodeficiency. Intravenous immunoglobulin (IVIg) refers to a medication developed from purified antibodies gathered from the plasma of thousands of healthy donors, aimed at modulating the immune system. For example, in August 2025, Octapharma, a Switzerland-based human protein products company known for its plasma-derived and recombinant therapies, launched Gamten 10% IVIg. This intravenous immunoglobulin (IVIg) product, derived from UK-donated human plasma, was introduced under the UK Plasma for Medicines Programme to deliver immunoglobulin replacement therapy for patients with either primary or secondary immunodeficiency. Additionally, the company also provides other specialized treatments, including those for coagulation factors and critical care conditions.

Who Are The Companies Operating Across The Blood Plasma Derivatives Market Value Chain?

Major companies operating in the blood plasma derivatives market are Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Get The Full Blood Plasma Derivatives Market Report:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Where Is The Blood Plasma Derivatives Market Most Concentrated Geographically?

North America was the largest region in the blood plasma derivatives market in 2025. The regions covered in the blood plasma derivatives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Blood Plasma Derivatives Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Browse Through More Reports Similar to the Global Blood Plasma Derivatives Market 2026, By The Business Research Company

Plasma Powder Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Plasma Protein Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795